Release Date: 22/07/16 19:18 Summary: Second Supplementary Bidders Statement,GXY-GMM.AX Price Sensitive: Yes Download Document 377.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%